| Code | CSB-MP019049HUc7 |
| Abbreviation | Recombinant Human PTPRC protein, partial (Active) |
| MSDS | |
| Size | $138 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
CD45 orchestrates T-cell and B-cell activation by dephosphorylating Src family kinases, making its extracellular domain a critical target for therapeutic antibody development and immune modulation studies. This mammalian-expressed fragment spanning residues 26–577 captures the membrane-proximal extracellular region with native glycosylation patterns that preserve conformational epitopes, as demonstrated by its binding to an anti-PTPRC recombinant antibody with an EC50 of 25.15–29.54 ng/mL in functional ELISA. The quantified binding affinity supports use in competitive inhibition assays for blocking antibody screening, therapeutic antibody epitope mapping, and ligand-receptor interaction studies by surface plasmon resonance or biolayer interferometry. With purity exceeding 95% by SDS-PAGE and endotoxin levels below 1.0 EU/μg, this protein meets the quality thresholds commonly required for antibody validation workflows and serves as a positive control in binding assays where reproducible receptor presentation is essential.
There are currently no reviews for this product.